Literature DB >> 9929757

Angiotensin-converting enzyme inhibitor-induced pancreatitis.

J S Muchnick1, J L Mehta.   

Abstract

Approximately 2% of pancreatitis in adults is drug induced. Although some angiotensin-converting enzyme (ACE) inhibitors have been associated with pancreatitis, to the knowledge of the authors this is the first reported case involving benazepril. This case report presents laboratory- and image-proven pancreatitis in a noninsulin dependent 70-year-old man. The patient took benazepril at three different times and experienced the same epigastric symptoms 30 min after each dose. Possible mechanisms are reviewed. Clinicians should strongly consider discontinuing ACE inhibitors, including benazepril, in patients with pancreatitis of no identifiable source.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9929757      PMCID: PMC6655718          DOI: 10.1002/clc.4960220117

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

1.  Acute pancreatitis due to captopril treatment.

Authors:  A Iliopoulou; G Giannakopoulos; H Pagoy; T Christos; S Theodore
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

2.  A case of fatal necrotizing pancreatitis: complication of hydrochlorothiazide and lisinopril therapy.

Authors:  Sareen Bedrossian; Bobbak Vahid
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

3.  Sitagliptin-induced pancreatitis - a longer road than expected.

Authors:  Matthew Nelson; Niyati Bhandari; Jill Wener
Journal:  Clin Case Rep       Date:  2014-06-06

Review 4.  Ever-increasing diversity of drug-induced pancreatitis.

Authors:  Simcha Weissman; Muhammad Aziz; Ryan B Perumpail; Tej I Mehta; Rutwik Patel; James H Tabibian
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

5.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.